Coronavirus: Oxford University to test Covid-19 vaccine response among children for first time

By: |
Updated: February 13, 2021 4:35 PM

The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.

coronavirus vaccineEven after vaccination, masks and other guidelines laid down for the Coronavirus infection need to be followed.

The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.

The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.

Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.

The two-dose Oxford/AstraZeneca vaccine has been hailed as a ‘vaccine for the world’ because it is cheaper and easier to distribute than some rivals.

AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Kerala sees 12,708 new COVID-19 infections; total case tally surges past 28.55 lakh
2Covid Effect: Ayurveda immunity products demand spike in Delhi, Mumbai, Bangalore during 2nd wave
3Karnataka Unlock: Mysuru only district to be under curbs; health officials send samples for genome sequencing